SEC 13F Intelligence

Duquesne Family Office LLC / COGT

Duquesne Family Office LLC’s Cogent Biosciences Inc Position

Does Duquesne Family Office LLC own Cogent Biosciences Inc (COGT)? Not currently — the last reported position was 2.21M shares worth $79M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$79M
Q4 2025
Shares
2.21M
% of Portfolio
+1.75%
Quarters Held
2
position exited

Position History COGT

Reported value by quarter
Q3 ’25: $15MQ3 ’25Q4 ’25: $79MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20252.21M$79M+1.75%
Q3 20251.06M$15M+0.37%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Duquesne Family Office LLC’s full portfolio or all institutional holders of COGT.